Imbruvica — Net revenues
Products & Services · Net revenuesAbbVie Imbruvica — Net revenues decreased by 5.0% to $671.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 20.9%, from $848.00M to $671.00M. Over 4 years (FY 2021 to FY 2025), Imbruvica — Net revenues shows a downward trend with a -14.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Increasing revenue indicates strong market demand and successful commercial execution, while declining revenue suggests market saturation or competitive pressure.
Detailed definition
This metric represents the total net sales generated by the Imbruvica product line after accounting for returns, rebates...
Peer comparison
Comparable to 'Product Revenue' or 'Segment Revenue' for specific drug brands at other pharmaceutical companies.
abbv_segment_imbruvica_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.38B | $1.37B | $1.39B | $1.17B | $1.15B | $1.14B | $1.12B | $878.00M | $907.00M | $908.00M | $903.00M | $838.00M | $833.00M | $828.00M | $848.00M | $738.00M | $754.00M | $706.00M | $671.00M |
| QoQ Change | — | -0.5% | +0.8% | -15.3% | -2.4% | -0.9% | -1.8% | -21.3% | +3.3% | +0.1% | -0.6% | -7.2% | -0.6% | -0.6% | +2.4% | -13.0% | +2.2% | -6.4% | -5.0% |
| YoY Change | — | — | — | — | -17.1% | -17.4% | -19.5% | -25.1% | -20.8% | -20.0% | -19.0% | -4.6% | -8.2% | -8.8% | -6.1% | -11.9% | -9.5% | -14.7% | -20.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is AbbVie's imbruvica — net revenues?
- AbbVie (ABBV) reported imbruvica — net revenues of $671.00M in Q4 2025.
- How has AbbVie's imbruvica — net revenues changed year-over-year?
- AbbVie's imbruvica — net revenues decreased by 20.9% year-over-year, from $848.00M to $671.00M.
- What is the long-term trend for AbbVie's imbruvica — net revenues?
- Over 4 years (2021 to 2025), AbbVie's imbruvica — net revenues has grown at a -14.7% compound annual growth rate (CAGR), from $5.41B to $2.87B.
- What does imbruvica — net revenues mean?
- The total net sales revenue generated by the Imbruvica product line.